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Background:  Mild therapeutic  hypothermia  interferes  with  multiple  cascades  of the
ischaemia/reperfusion  injury  that is  known  as  primary  mechanism  for brain  damage  after  cardiac
arrest.  First  resuscitation  attempts  and  the  duration  of  resuscitation  efforts  will  initiate  and  aggravate
this  pathophysiology.  Therefore  we  investigated  the  interaction  between  the  duration  of  basic  and
advanced  life  support  and  outcome  after  cardiac  arrest  in patients  treated  with  or  without  mild
therapeutic  hypothermia.
Methods: This  retrospective  cohort  study  included  patients  18 years  of age  or  older  suffering  a witnessed
out-of-hospital  cardiac  arrest  with  presumed  cardiac  cause,  which  remained  comatose  after  restoration
of spontaneous  circulation.  The  basic  and  advanced  life  support  ‘low-ﬂow’  time,  categorized  into  four
quartiles  (0–11,  12–17,  18–28,  ≥29  min),  was  correlated  with  neurological  outcome.
Results:  Out  of 1103  patients  613 were  cooled  to a target  temperature  of 33 ± 1 ◦C  for  24 h. In the  three
quartiles  with  ‘low-ﬂow’  time  up to 28  min  cooling  was  associated  with  >2-fold  odds  of  favourable  neu-
rological  outcome.  In the  fourth  quartile  with  ‘low-ﬂow’  time  of  ≥29  min  cooling  had  no inﬂuence  on
neurological  outcome  (OR:  0.73;  95% CI: 0.38–1.4,  test  for interaction  p < 0.01).
Conclusion:  The  duration  of resuscitation  efforts,  deﬁned  as  ‘low-ﬂow’  time,  inﬂuences  the  effectiveness  of
mild  therapeutic  hypothermia  in  terms  of neurologic  outcome.  Patients  with  low  to  moderate  ‘low-ﬂow’
time beneﬁt  most  from  this  treatment.
rs.  Pu© 2015  The  Autho
ntroduction
Sudden cardiac arrest leads to an immediate breakdown of per-
usion followed by global ischaemia.1–6 In 1987 Bulkley postulated
 bimodal model of injury after prolonged ischaemia followed by
eperfusion.7 Ischaemic tissue injury dominates the ﬁrst phase and
he extent of damage is mainly due to the duration of ischaemia
er se. Oxygen supply is reintroduced to the tissue when perfusion
s restored. This leads to further biochemical changes, which are
lready initiated during ischaemia. The consequences of these reac-
ions are the generation of reactive oxygen species and inﬁltration
f pro-inﬂammatory processes in the reperfusion phase.
 A Spanish translated version of the abstract of this article appears as Appendix
n  the ﬁnal online version at http://dx.doi.org/10.1016/j.resuscitation.2015.09.400.
∗ Corresponding author.
E-mail address: christoph.testori@meduniwien.ac.at (C. Testori).
ttp://dx.doi.org/10.1016/j.resuscitation.2015.09.400
300-9572/© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access
c-nd/4.0/).blished  by Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
It has been shown that mild therapeutic hypothermia in patients
after cardiac arrest increases the rate of favourable neurologic
outcome and decreases mortality.8–13 Rather than interacting
with a particular pathway of post-ischaemic reperfusion dam-
age, hypothermia inﬂuences multiple reactions which lead to cell
death.6 However, the exact mechanisms of neuroprotection are still
unknown and are still a matter of current research. A large random-
ized controlled trial published in 2013 failed to show superiority of
mild therapeutic hypothermia over controlled normothermia for
neurologic recovery after cardiac arrest.14 This leads to the question
of whether therapeutic hypothermia is applicable as an ‘one-ﬁts-all’
therapy in post resuscitation care.
In 2012 Testori et al. demonstrated a higher effectiveness of mild
therapeutic hypothermia in patients with a longer duration of com-
plete circulatory standstill (‘no-ﬂow’ time).13 If reperfusion starts
within 2 min  after circulatory breakdown, post restoration of spon-
taneous circulation mild therapeutic hypothermia seems to have
no positive impact on outcome. If the duration of cardiac stand-
still is longer, a harmful process arises and is exacerbated during
 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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aFig. 1. Patient ﬂowchart. CPR, cardiopulmonary
eperfusion. Even a sub-physiological ‘low-ﬂow’ state, generated
y resuscitation efforts, may  already initiate these deleterious cas-
ades leading to cell damage.3–5 A mechanism including systemic
nﬂammatory response, apoptosis, and a breakdown of the blood-
rain-barrier is initiated and leads to neuronal damage.6 Even after
eturn of spontaneous circulation these processes proceed.
Whether the duration of the sub-physiological perfusion dur-
ng cardiopulmonary resuscitation worsens ischaemia/reperfusion
njury is unknown. Therefore we hypothesized that a prolonged
on-hypothermic ‘low-ﬂow’ state lessens the neuro-protective and
urvival beneﬁts which could be achieved with mild therapeutic
ypothermia in patients successfully resuscitated from out-of-
ospital cardiac arrest.
ethods
This trial was a retrospective cohort analysis based on prospec-
ively collected data between January 1992 and August 2011 from
he Vienna Clinical Cardiac Arrest Registry. The registry contains all
dult out of hospital cardiac arrest patients, admitted and treated at
he Department of Emergency Medicine of the Medical University
f Vienna. The institutional ethical review board has approved this
egistry (ethic committee number: 1814/2012). Acquisition and
ocumentation of data were performed according to the ‘Utstein
tyle Criteria’.15
tudy population
The study population comprises patients with witnessed out
f hospital cardiac arrest of presumed cardiac origin and who
emained comatose (Glasgow coma scale ≤ 8) after restoration of
pontaneous circulation. Patients younger than 18 years of age,
atients with traumatic or cerebrovascular cause of arrest, pre-
xisting severe neurological or overall deﬁcits (deﬁned as cerebral
erformance category > 2 or overall performance category > 2) as
ell as patients with a core temperature of <30 ◦C were excluded.xposure
To determine whether the protective effect of hypothermia is
ltered by the duration of resuscitation efforts, ‘low-ﬂow’ time wasscitation; MTH, mild therapeutic hypothermia.
a priori split into four quartiles (1st quartile 0–11 min; 2nd 12–17;
3rd 18–28; 4th equal or greater than 29 min). Subsequently within
these quartiles patients receiving treatment with mild therapeutic
hypothermia were compared to those not treated with hypother-
mia.
‘Low-ﬂow’ time was  deﬁned as the time period from the start
of resuscitation efforts until restoration of spontaneous circulation.
Life support was  begun either by lay persons (bystanders, relatives)
or professionals (emergency physicians, paramedics) on the scene.
Quality of bystander basic life support was  evaluated visually by the
arriving EMS  crew on the scene and was  documented as sufﬁcient
or not. If bystander resuscitation was  considered insufﬁcient it was
documented as no basic life support. Patients who received mild
therapeutic hypothermia were cooled to a target temperature of
32–34 ◦C for 24 h.
Outcome
The primary outcome was best ever achieved neurologic con-
dition within a 6 month observation period. Cerebral function was
assessed prospectively on arrival at the emergency department and
at predeﬁned time points up to 6 months after restoration of spon-
taneous circulation and was expressed in terms of the Pittsburgh
cerebral performance categories (CPC). A performance score of 1
(good function) or 2 (moderate disability) on a 5-category scale
was considered as a good neurologic recovery; the other categories
were 3 (severe disability), 4 (vegetative state), and 5 (brain death).
The secondary outcome was overall survival rate assessed at 6
months.
Statistical analysis
Continuous variables are reported as median and interquartile
range. Categorical variables are presented as absolute and rela-
tive frequencies. Primary and secondary outcomes were binary,
and the chi-square test was used to compare the outcomes
between groups. All effects were calculated using multivariate
logistic regression models to estimate the association between
mild therapeutic hypothermia and neurological recovery while
allowing for potential confounders and including interaction terms
for the levels of ‘low-ﬂow’ time quartiles. Therefore we  initially
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ncluded all available confounder candidate variables which, from
 clinical point of view, may  be associated with the outcome
nd with cooling: sex, age, basic life support (yes/no), shock-
ble rhythm in the initial ECG (yes/no), ‘no-ﬂow’ time (time
rom cardiac arrest until initiation of resuscitation efforts (min-
tes)), median lactate level (mmol/l), and cumulative adrenalin
osage (mg). Continuous variables were examined for any pos-
ible linear associations with the outcome. To keep the most
arsimonious model, we excluded variables that did not change
he effect size of the primary risk factors by more than 10%. A
wo-sided p-value of <0.05 was generally considered statistically
igniﬁcant.
esults
From 1992 to 2011 a total of 4002 patients with cardiac arrest
ere registered in our database. Out of these 1103 fulﬁlled the
nclusion criteria for further analysis. A ﬂowchart is presented in
ig. 1.
Baseline characteristics of the analysed patients are presented in
able 1. Patients treated with mild therapeutic hypothermia were
igniﬁcantly younger, less frequently female, had a higher rate of
asic life support and a higher rate of initial shockable rhythm,
eceived a less cumulative dose of adrenaline and showed a lower
erum lactate in the ﬁrst blood-gas analysis after hospital admis-
ion.
rimary outcome
In spite of showing a statistically signiﬁcant improvement in
avourable neurologic outcome in all patients treated with mild
herapeutic hypothermia (odds ratio [OR]: 1.49; 95% conﬁdence
nterval [CI]: 1.10–2.01) this effect varies with the duration of ‘low-
ow’ time (p for interaction = 0.007). Whereas a beneﬁcial effect of
ild therapeutic hypothermia was evident if ‘low-ﬂow’ time was
horter than 29 min  with a maximum beneﬁt in those patients with
 ‘low-ﬂow’ time less than 11 min  (OR: 2.89; 95% CI: 1.53–5.43), no
ffect was present in the 4th ‘low-ﬂow’ quartile (OR: 0.73; 95% CI:
.38–1.40) (Table 2).
econdary outcome
The secondary outcome showed an overall survival beneﬁt in
atients treated with mild therapeutic hypothermia (OR 1.48; CI
.10–2.00) and no effect when ‘low-ﬂow’ times were more than
9 min  (OR 1.04; CI 0.55–1.97) (Table 2). The effect of mild thera-
eutic hypothermia on survival was not signiﬁcantly modiﬁed by
low-ﬂow’ time (p for interaction = 0.09).
iscussion
The neuro-protective effect of mild therapeutic hypothermia
as signiﬁcantly associated with the duration of sub-physiological
erfusion during resuscitation efforts. While a beneﬁt was  seen in
atients with ‘low-ﬂow’ times of less than 29 min, in those with
low-ﬂow’ times of 29 min  or longer mild therapeutic hypothermia
as no longer associated with improved neurologic recovery.
Our results are supported by ﬁndings of experimental studies
ndicating that ischaemia/reperfusion injury appears to begin even
uring cardiopulmonary resuscitation.16–20 It seems that a pro-
onged period of sub-physiological perfusion worsens reperfusion
njury and therefore treating these processes, even with the appli-
ation of mild therapeutic hypothermia, may  no longer be possible.
Testori et al. were able to show that even in patients with pro-
onged time of complete circulatory standstill, the beneﬁcial effect
f mild therapeutic hypothermia was most distinct in patients with T
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Table 2
Univariate and multivariate outcome analysis.
No-hypothermia
No./total no. (%)
Hypothermia
No./total no. (%)
Odds ratio (95% CI) crude p-value Odds ratio (95% CI) adjusted
Good neurological outcome
Overall 171/490 (35) 328/613 (54) 2.15 (1.68–2.74) <0.001 1.49 (1.10–2.01)
Quartile 1 (0–11 min) 84/164 (51) 110/142 (77) 3.27 (1.99–5.39) <0.001 2.89 (1.53–5.43)
Quartile 2 (12–17 min) 29/100 (29) 93/146 (64) 4.30 (2.48–7.43) <0.001 2.26 (1.14–4.47)
Quartile 3 (18–28 min) 29/111 (26) 83/175 (47) 2.55 (1.52–4.28) <0.001 2.04 (1.12–3.71)
Quartile 4 (≥29 min) 29/115 (25) 42/150 (28) 1.15 (0.66–2.00) 0.612 0.73 (0.38–1.40)
Survival
Overall  185/490 (38) 356/613 (58) 2.28 (1.79–2.91) <0.001 1.48 (1.10–2.00)
Quartile 1 (0–11 min) 85/164 (52) 109/142 (77) 3.07 (1.87–5.04) <0.001 2.21 (1.17–4.17)
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1Quartile 2 (12–17 min) 32/100 (32) 96/146 (66) 
Quartile 3 (18–28 min) 38/111 (34) 97/175 (55) 
Quartile 4 (≥29 min) 30/115 (26) 54/150 (36) 
onger ‘no-ﬂow’ times.13 In patients where resuscitation efforts
egan immediately after cardiac arrest, no advantage of mild ther-
peutic hypothermia treatment was shown. When combining the
ata of Testori et al. with those of our current work an intriguing
onclusion could be drawn. Patients with a long circulatory stand-
till and short resuscitation period might beneﬁt the most from
ild therapeutic hypothermia. This suggests that this therapy will
robably have to be more personalized on patient characteristics
nd the process of resuscitation efforts. This might bring a new
iew on the optimal dosage and indication of post cardiac arrest
emperature management.
This association was already evident in the prospective ‘Tar-
eted Temperature Management’ trial by Nielsen et al.14 In this
tudy no positive effect of mild therapeutic hypothermia compared
o controlled normothermia was found. It is striking that patients in
his trial had a median ‘no-ﬂow’ time of 1 min  and a median ‘low-
ow’ period of 25 min. This combines a short time of circulatory
tandstill coupled with a relatively long duration of resuscitation
fforts and therefore supports the ﬁndings of the current analy-
is. On the other hand in the HACA-Trial median ‘no-ﬂow’ time was
 min  and a median ‘low-ﬂow’ time 17 min.11 With a positive effect
n outcome these study results are also congruent to our analysis.
Two recent publications on the inﬂuence of the time from col-
apse to return of spontaneous circulation showed contradictory
esults.21,22 Whereas Kaneko et al. demonstrates a beneﬁcial effect
f mild therapeutic hypothermia for patients with a resuscitation
nterval of below 30 min  a sub-study of the ‘Targeted Tempera-
ure Management’ trial showed no such effect. Without separating
no-ﬂow’ and ‘low-ﬂow’ time these results might not reﬂect the
athophysiological rational behind ischaemia and reperfusion.
A major limitation of our investigation was its retrospective
ingle centre nature. This study derived from an observational
nd descriptive registry, and the database therein comprises only
atients who were admitted to our department. A selection bias
ight have occurred, because the ﬁnal decision to cool a patient
as left to the discretion of the attending physician. Therefore,
t is possible that a higher proportion of patients with expected
nfavourable outcome were not cooled. Also baseline charac-
eristics were not similar across all groups. We  attempted to
ompensate for this possible bias by adjusting for all known con-
ounders that may  have inﬂuenced our results in a multivariate
egression model. The observational period was relatively long and
eneral intensive care treatment strategies have changed over the
ast 18 years. But as this will inﬂuence all time-quartiles, we do not
hink that this could have had a major impact on our results.onclusion
In conclusion our analysis showed an association between the
ime of resuscitation efforts and the effectiveness of treatment with
1
14.08 (2.37–7.01) <0.001 2.27 (1.13–4.55)
2.39 (1.46–3.91) 0.001 1.88 (1.05–3.37)
1.59 (0.93–2.72) 0.087 1.04 (0.55–1.97)
mild therapeutic hypothermia on outcome. Especially for patients
with short times of cardiopulmonary resuscitation mild therapeutic
hypothermia had a signiﬁcant beneﬁt for neurological outcome.
Due to the retrospective nature of this study the presented data
can only be hypothesis generating and more research on this topic
is mandatory.
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